Education
About Us
Working with TipRanks
Follow Us
Cabaletta Bio (CABA)
NASDAQ:CABA
Total Valuation
Cabaletta Bio has a market cap or net worth of $121.65M. The enterprise value is -$75.74M.
Market Cap$121.65M
Enterprise Value-$75.74M
Share Statistics
Cabaletta Bio has 91,465,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,465,230
Owned by Insiders1.74%
Owned by Institutions0.01%
Financial Efficiency
Cabaletta Bio’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -70.34%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-70.34%
Return on Capital Employed (ROCE)-0.79
Revenue Per Employee0.00
Profits Per Employee-719.65K
Employee Count161
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cabaletta Bio is ―. Cabaletta Bio’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.74
Price to FCF―
Price to Operating Cash Flow-1.01
PEG Ratio―
Income Statement
In the last 12 months, Cabaletta Bio had revenue of 0.00 and earned -115.86M in profits. Earnings per share was -2.34.
Revenue0.00
Gross Profit-4.81M
Operating Income-125.14M
Pretax Income-115.86M
Net Income-115.86M
EBITDA-125.14M
Earnings Per Share (EPS)-2.34
Cash Flow
In the last 12 months, operating cash flow was -104.67M and capital expenditures -1.57M, giving a free cash flow of -106.25M billion.
Operating Cash Flow-104.67M
Free Cash Flow-106.25M
Free Cash Flow per Share-1.16
Dividends & Yields
Cabaletta Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.88
52-Week Price Change-60.96%
50-Day Moving Average1.71
200-Day Moving Average2.12
Relative Strength Index (RSI)57.70
Average Volume (3m)1.18M
Important Dates
Cabaletta Bio upcoming earnings date is Nov 12, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
Cabaletta Bio as a current ratio of 6.15, with Debt / Equity ratio of 13.95%
Current Ratio6.15
Quick Ratio6.15
Debt to Market Cap0.14
Net Debt to EBITDA1.19
Interest Coverage Ratio-167.30
Taxes
In the past 12 months, Cabaletta Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cabaletta Bio EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 0.40.
EV to Sales0.00
EV to EBITDA0.29
EV to Free Cash Flow0.40
EV to Operating Cash Flow0.41
Balance Sheet
Cabaletta Bio has $194.68M in cash and marketable securities with $24.89M in debt, giving a net cash position of -$169.79M billion.
Cash & Marketable Securities$194.68M
Total Debt$24.89M
Net Cash-$169.79M
Net Cash Per Share-$1.86
Tangible Book Value Per Share$3.08
Margins
Gross margin is -34.07%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-34.07%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cabaletta Bio is $12.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.43
Price Target Upside626.90% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast-41.69%